AVERT trial demonstrates high rates of DAS-defined remission with Orencia® in co

Bristol-Myers Squibb has announced its first release of new data from a phase IIIb RA trial showing that the T-cell co-stimulation modulator, abatacept, in combination with methotrexate (MTX)...

More...